BackLongboard Pharmaceuticals Overview

Longboard Pharmaceuticals EBIT

EBIT (Earnings Before Interest and Taxes) analysis for LBPH.

Quarterly EBIT

-$28.12M
↓ 107.05% YoY

As of Sep 30, 2024

Annual EBIT (TTM)

-$87.45M
↓ 65.27% YoY

Trailing 12 months ending Sep 30, 2024

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin